CASTRATION RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo slows prostate cancer in Late-Stage trial
Disease control OngoingThis study tests whether adding the drug niraparib to standard therapy (abiraterone and prednisone) can help men with metastatic prostate cancer that no longer responds to hormone therapy. About 765 participants received either the combo or a placebo. The main goal is to see if t…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 07:41 UTC
-
Prostate cancer drugs may cloud your mind – study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for advanced prostate cancer affect men's thinking skills, like memory and concentration. Researchers will use brain scans and thinking tests to see if these treatments cause changes in the brain. The goal is to understand why som…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC